Methods of treating retinal diseases
US11400070B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | May 2, 2019 |
| Grant date | Aug 2, 2022 |
| Priority date | — |
| Expiry date | May 2, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating or inhibiting degeneration of a retina of a subject in need thereof comprising administering an effective amount of a compound of metipranolol, or a metabolite thereof, to an organ, a tissue, or the subject, wherein the degeneration of the retina is caused by an ocular disease. In some embodiments, the compound, or a metabolite thereof, is administered topically, orally, or parenterally. In some embodiments, a drug delivery vehicle comprising a dosage of the compound, or the metabolite of, is delivered parenterally via intravitreal injection. In further embodiments, the dosage may range from 0.5 μg/day-15 μg/day.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.